Navigation Links
New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director

Following a two-month transition, Paul Pomerantz, MBA, CAE, officially has begun his work as the new worldwide executive director of the Drug Information Association (DIA).

Horsham, PA, USA (Vocus) December 4, 2009 -- Following a two-month transition, Paul Pomerantz, MBA, CAE, officially has begun his work as the new worldwide executive director of the Drug Information Association (DIA). Pomerantz was previously the executive vice president of the American Society of Plastic Surgeons (ASPS). He replaces William Brassington, MBA, who has served as DIA’s acting executive director since July 2008. Brassington will resume his role as DIA worldwide director of finance.

“As part of my transition, I was extremely fortunate to be able to contribute to the board of director’s strategic planning regarding an expanded vision and mission for DIA,” said Pomerantz. “Those conversations are critical at this moment because of the rapidly changing global healthcare landscape. Our job is to ensure that our programming remains relevant and meaningful for our members and volunteers, and I am confident that our long-term strategic plan and revised mission and vision will allow us to collectively make an impact on improving healthcare worldwide.”

Most significantly, the new DIA vision and mission raises the association’s role from a neutral venue for sharing best practices to one that facilitates the knowledge that is needed to raise the level of health and well being worldwide. Pomerantz is charged with ensuring that the essence of the new vision and mission statements are incorporated into all aspects of DIA’s educational programming and operations. Along with that, Paul is responsible for directing DIA’s global operations and strategic expansion and for leading the implementation of the board of director’s long-term plan for sustainability and growth.

Pomerantz brings to DIA more than 30 years of executive experience with specialized expertise in health policy, medical society management, and health administration.

“It’s not often that the timing around an exciting new strategy coincides with the start of new, passionate leadership, but DIA is fortunate to have both,” said DIA Board President Jeff Sherman. “I know Paul agrees that for us to truly meet our mission, we need to build relationships with new scientific, industry, academic, patient, and regulatory stakeholders who can contribute to the value of our global, multidisciplinary, and neutral educational and networking forum. We hope that this new vision and mission will help to reinforce the work we’re doing together to raise the level of health worldwide.”

To see the complete and expanded DIA Vision and Mission Statements, please visit

About the Drug Information Association (DIA)
As a nonprofit member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. DIA fosters innovation of products, technologies, and services to improve health and well being worldwide by providing indispensible forums to exchange vital information and discuss current issues, delivering customized learning experiences, building, maintaining, and facilitating trusted relationships with and among individuals and organizations that drive and share DIA values and mandates, and providing a multidisciplinary neutral environment, respected globally for integrity and relevancy. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit or call 215-442-6100.

Joe Krasowski

Christine Reimert
Devine + Powers

Lucy MacNichol
Devine + Powers


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Brandeis studies evaluate visionary approach to improving eyesight
2. NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions
3. Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products
4. Ophthalmic Equipment Distributor, Latham & Phillips SE Division, Unveils Website
5. New Haven Dental Group Expands Their Vision
6. U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability
7. Tarkett Sports' Indoor Division Grows as Warthan Associates Join North American Distribution Network
8. Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces The Creation Of New Business Division Nationwide Medical Equipment Services
9. Mach 7 Technologies Releases New Revision of Flagship Keystone Suite(TM) Enterprise Image Management Platform
10. US Farms, Inc. Announces Completion of Construction for New 3000 Square Foot Greenhouse Shipping and Packing Facility for Nursery Division
11. Employer, Medicare Provisions of House Health Care Reform Detailed in New CCH Briefing
Post Your Comments:
Related Image:
New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 
(Date:12/1/2015)... ... 02, 2015 , ... Ruth Pearson was struggling. She had been laid off ... assistance and quickly losing hope of recovering her former life, Pearson was desperate for ... attending a women’s retreat when she experienced a particularly impactful worship service. Without help ...
(Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday ... to NASDAQ to educate the personnel on spinal decompression therapy and offer his ... a nonsurgical procedure. The benefits come from creating negative intradiscal pressure which is ...
(Date:12/1/2015)... ... December 01, 2015 , ... Henderson, a ... to receive Gigabit Internet through a partnership this year with Aeneas Internet and ... is an attractive destination for entrepreneurs who want to build a business. Whether ...
(Date:12/1/2015)... ... , ... Florida Hospital Tampa is the first health care provider in the region ... , vBloc® Therapy is a vagal blocking therapy, delivered via the Maestro® System, for the ... (BMI) of at least 40 to 45 kg, or a BMI of at least 35 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Califia ... today announced that its iconic bottle has won top honors in Beverage World Magazine’s ... The Company also announced that it has been selected as a 2015 U.S.A. Taste ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... --> --> ... by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, Vaccines, (Therapeutic ... Analysis - Global Forecast to 2020", published by MarketsandMarkets, the ... Million by 2020 from USD 40,281.6 Million in 2015, at ... Browse 37 market data T ...
(Date:12/1/2015)... 2015 Assurex Health, Inc. today announced ... healthcare providers an expanded range of options in ... from depression, anxiety, bipolar disorder, posttraumatic stress disorder ... i .   --> ... addition of two new drug classes, 17 FDA-approved ...
(Date:12/1/2015)... , Dec. 1, 2015  Six months of adjunctive metformin ... type 1 diabetes, according to new research from T1D ... it may have a beneficial effect on measures of obesity, ... issue of the Journal of the American Medical Association ... the effect of metformin on overweight and obese adolescents with ...
Breaking Medicine Technology: